Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

209 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Update on glioma biotechnology.
Abrams M, Reichman N, Khatri D, Patel NV, D'Amico RS, Wong T, Fralin S, Li M, Symons M, Langer D, Filippi CG, Boockvar JA. Abrams M, et al. Among authors: boockvar ja. Clin Neurol Neurosurg. 2020 Aug;195:106075. doi: 10.1016/j.clineuro.2020.106075. Epub 2020 Jul 7. Clin Neurol Neurosurg. 2020. PMID: 32653731 Review.
Safety and maximum tolerated dose of superselective intraarterial cerebral infusion of bevacizumab after osmotic blood-brain barrier disruption for recurrent malignant glioma. Clinical article.
Boockvar JA, Tsiouris AJ, Hofstetter CP, Kovanlikaya I, Fralin S, Kesavabhotla K, Seedial SM, Pannullo SC, Schwartz TH, Stieg P, Zimmerman RD, Knopman J, Scheff RJ, Christos P, Vallabhajosula S, Riina HA. Boockvar JA, et al. J Neurosurg. 2011 Mar;114(3):624-32. doi: 10.3171/2010.9.JNS101223. Epub 2010 Oct 22. J Neurosurg. 2011. PMID: 20964595 Free PMC article. Clinical Trial.
Industry progress report on neuro-oncology: a biotech update.
Haber JS, Banu MA, Ray A, Kesavabhotla K, Boockvar JA. Haber JS, et al. Among authors: boockvar ja. J Neurooncol. 2013 Apr;112(2):315-21. doi: 10.1007/s11060-012-1036-8. Epub 2013 Feb 20. J Neurooncol. 2013. PMID: 23423513
Repurposing mebendazole for the treatment of medulloblastoma.
Bodhinayake I, Symons M, Boockvar JA. Bodhinayake I, et al. Among authors: boockvar ja. Neurosurgery. 2015 Feb;76(2):N15-6. doi: 10.1227/01.neu.0000460594.93803.cb. Neurosurgery. 2015. PMID: 25594199 No abstract available.
Neuro-oncology biotech industry progress report.
Chakraborty S, Bodhinayake I, Chiluwal A, Langer DJ, Ruggieri R, Symons M, Boockvar JA. Chakraborty S, et al. Among authors: boockvar ja. J Neurooncol. 2016 May;128(1):175-182. doi: 10.1007/s11060-016-2087-z. Epub 2016 Feb 20. J Neurooncol. 2016. PMID: 26897014 Review.
Superselective intraarterial cerebral infusion of cetuximab after osmotic blood/brain barrier disruption for recurrent malignant glioma: phase I study.
Chakraborty S, Filippi CG, Wong T, Ray A, Fralin S, Tsiouris AJ, Praminick B, Demopoulos A, McCrea HJ, Bodhinayake I, Ortiz R, Langer DJ, Boockvar JA. Chakraborty S, et al. Among authors: boockvar ja. J Neurooncol. 2016 Jul;128(3):405-15. doi: 10.1007/s11060-016-2099-8. Epub 2016 Mar 5. J Neurooncol. 2016. PMID: 26945581 Clinical Trial.
Dynamic Susceptibility Contrast-Enhanced MR Perfusion Imaging in Assessing Recurrent Glioblastoma Response to Superselective Intra-Arterial Bevacizumab Therapy.
Singh R, Kesavabhotla K, Kishore SA, Zhou Z, Tsiouris AJ, Filippi CG, Boockvar JA, Kovanlikaya I. Singh R, et al. Among authors: boockvar ja. AJNR Am J Neuroradiol. 2016 Oct;37(10):1838-1843. doi: 10.3174/ajnr.A4823. Epub 2016 May 26. AJNR Am J Neuroradiol. 2016. PMID: 27231225 Free PMC article.
209 results